{
    "title": "CVS introduces generic version of the EpiPen costing less than one sixth of the real thing after makers hiked the price to $600",
    "url": "https://www.dailymail.co.uk/news/article-4114270/CVS-introduces-generic-version-EpiPen-called-Adrenaclick.html",
    "date": "2017-01-12",
    "keywords": [
        "price",
        "cvs",
        "version",
        "chain",
        "bresch",
        "drug",
        "maker",
        "treatment",
        "cost",
        "health",
        "epinephrine",
        "percent",
        "coverage",
        "share",
        "september",
        "part",
        "drugmaker",
        "customer",
        "pharmacy",
        "lifesaving",
        "allergy",
        "congress",
        "drugstore",
        "twopack",
        "adrenaclick",
        "corp",
        "cent",
        "target",
        "anaphylaxis",
        "eggsthe",
        "hormone",
        "year",
        "onemylan",
        "heat",
        "summer",
        "pricing",
        "cigna",
        "martin",
        "shkreli",
        "twitter",
        "doctor",
        "article",
        "panel",
        "ceo",
        "heather",
        "debt",
        "donald",
        "trump",
        "wednesday",
        "press",
        "conference",
        "bidding",
        "money",
        "epipen",
        "form",
        "name",
        "brand",
        "pressure",
        "today",
        "decline",
        "stock",
        "trading",
        "aftermath",
        "attention",
        "mylan",
        "aid",
        "generic",
        "december",
        "twopackbut",
        "insurance",
        "care",
        "assistance",
        "hearing",
        "cash",
        "counterprescription",
        "benefit",
        "thursday",
        "goodrx",
        "impax",
        "coupon",
        "program",
        "patient"
    ],
    "category": [
        "news"
    ]
}